Jose Alvarez-Cardona

Cardio-oncology is an emerging subspecialty addressing the cardiovascular toxicities of cancer treatments — from anthracycline-induced cardiomyopathy to trastuzumab cardiac dysfunction, radiation-induced coronary artery disease, VEGF inhibitor hypertension, and immune checkpoint inhibitor-associated myocarditis. Specialized cardio-oncology programs provide cardiovascular risk assessment, monitoring, and management to optimize cardiac health during and after cancer treatment.